What Did We Learn about AI Progress at RSNA24? A Lot, Actually
RSNA24 showcased important progress in leveraging AI for multiple important purposes
December 2024
Read More
Hospitals Are Facing New Price Transparency Requirements, But Will They Truly Help Patients Shop for Care?
Come January 1, CMS will begin enforcing new price transparency requirements for hospitals. Experts doubt that these regulations will do much to help patients shop for care, but they are optimistic that increasing the amount of publicly available pricing data will help tech companies develop tools that simplify pricing for patients. The post Hospitals Are…
The Big 3 PBMs are Countersuing the FTC. Does Their Argument Have Any Teeth?
After the FTC filed a lawsuit in September, accusing the three major pharmacy benefit managers of anticompetitive rebating practices related to insulin, the defendants reversed roles and became plaintiffs. In November, they countersued the agency, arguing that its lawsuit is unconstitutional. The post The Big 3 PBMs are Countersuing the FTC. Does Their Argument Have…
More than a Third of the US has Dental Anxiety. Here’s How New Technology is Improving Patient Trust
The integration of the latest technologies improves diagnostic quality and accelerates treatment solutions, decreasing the time patients spend in discomfort or pain due to dental issues. The post More than a Third of the US has Dental Anxiety. Here’s How New Technology is Improving Patient Trust appeared first on MedCity News.
Endometriosis: The Complex, Whole-body Disease We Need to be Talking About
Through the years, I’ve seen 12 different GI specialists, countless gynecologists, and many other specialists. I’ve had at least 10 surgeries and procedures. Here are three ways to prevent your patients from going through the same thing. The post Endometriosis: The Complex, Whole-body Disease We Need to be Talking About appeared first on MedCity News.
Safety Signal in Phase 2 Deals a Setback to BioAge Labs’ Muscle-Preserving Obesity Drug
BioAge Labs said the potential safety problem was observed in some who received experimental drug azelaprag, which is being tested as a monotherapy and in combination with Eli Lilly obesity medication Zepbound. No safety signals were observed in those who received Zepbound alone. The post Safety Signal in Phase 2 Deals a Setback to BioAge…
Journalists Dig Into Vaccine Debate and America’s Obesity Rates
KFF Health News senior correspondent Arthur Allen discussed the fragility of our vaccine infrastructure on The Atlantic’s “Radio Atlantic” on Dec. 5. Click here to hear Allen on “Radio Atlantic” Read Allen’s “Scientists Fear What’s Next for Public Health if RFK Jr. Is Allowed To ‘Go Wild’” KFF Health News contributor Andy Miller discussed U.S….
Financial Incentives and Caregiving Decisions
This is the subtitle of a study by Rebaudo et al. (2024) that aims to examine how different factors impact individual willingness to provide caregiving. The study is focused on potential caregivers in Germany. Before we get to the statistical analysis, first some background: Informal Caregiving in Germany The article provides a nice summary of…
Why One CEO Is Excited About Breast Imaging AI
Volpara Health CEO Teri Thomas thinks AI will shape the future of radiology. This belief is a major reason why Volpara combined with South Korean AI company Lunit earlier this year, she said. The post Why One CEO Is Excited About Breast Imaging AI appeared first on MedCity News.
Hinge Health, Amazon Health Services Team Up to Broaden Access to MSK Care
Hinge Health is the first musculoskeletal care provider to be added to Amazon’s Health Condition Programs. The post Hinge Health, Amazon Health Services Team Up to Broaden Access to MSK Care appeared first on MedCity News.